Treatments for Recovery of Hand Function in Acute Stroke Survivors

November 27, 2018 updated by: Jayme Knutson, MetroHealth Medical Center

Contralaterally Controlled Functional Electrical Stimulation for Hemiparetic Hand

Impaired hand function is one of the most frequently persisting consequences of stroke. The purpose of this study is to investigate whether two different types of treatment improve recovery of hand function after stroke.

Study Overview

Status

Completed

Detailed Description

Loss of hand function is common after stroke. Previous research suggests that treatments that focus on movement of both hands at the same time or treatments that electrically stimulate the paretic (weak) hand muscles may help the recovery of hand function after stroke. In this study, two electrical stimulation treatments will be compared in their effectiveness in restoring hand movement and hand function. One of the treatments is stimulation only, and the other is stimulation linked to movement of the contralateral hand.

Study participants will be stroke survivors who are enrolled while they are still within their first 6 months after their stroke. After enrolling, their hand movement and function will be tested. Then they will be randomly assigned to one of the two treatments. Each treatment will last 6 weeks. The treatment will require the participant to perform specific exercises at home for a total of 2 hours every day and to come to the laboratory twice a week for study-related occupational therapy. At the end of the 6-week treatment, tests of hand movement and hand function will be repeated. The same tests will be repeated again at 1 and 3 months after the end of treatment to see if the effects of the treatment persist as time goes on. Changes in upper extremity impairment and activity limitation will be compared across treatment groups.

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44109
        • MetroHealth Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18 to 80
  • Within 6 months of first clinical hemorrhagic or nonhemorrhagic stroke
  • Cortical or subcortical stroke
  • Unilateral upper extremity hemiparesis with severe finger extensor and flexor paresis (<= grade 4 on Medical Research Council (MRC) scale)
  • Adequate movement of the shoulder and elbow to allow volitional positioning of the affected hand in the workspace.
  • Surface NMES of finger and thumb extensors produces functional hand opening without pain
  • Full volitional opening of the contralateral hand of the unimpaired side.
  • Able to follow 3 stage commands
  • Able to remember at least 2 of 3 items after 30 minutes
  • Able to hear and respond (by opening the less affected hand) to auditory cues issued from the stimulator?
  • Caregiver available and willing to help assist with the device and home regimen and ensure compliance
  • Skin intact on hemiparetic arm
  • Medically stable

Exclusion Criteria:

  • Insensate forearm and/or hand
  • Edema of the affected forearm and/or hand
  • History of potentially fatal cardiac arrhythmias.
  • Cardiac pacemakers or any other implanted electronic systems
  • Pregnant women
  • Uncontrolled seizure disorder
  • Severely impaired cognition or comprehension
  • Uncompensated hemineglect
  • Severe depression (>= 13 on Beck Depression Inventory Fast Screen)
  • Ipsilateral lower motor neuron lesion
  • Parkinson's Disease
  • Spinal cord injury
  • Traumatic brain injury
  • Multiple sclerosis
  • Lack of functional passive range of motion of the wrist or fingers of affected side
  • Severe shoulder or hand pain (unable to volitionally position hand in the workspace without pain)
  • Intramuscular botulinum toxin injections in upper extremity muscle in the last 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CCFES

CCFES - Contralaterally Controlled Functional Electrical Stimulation

  • Stimulation to finger and thumb extensors and flexors only in response to and with an intensity proportional to opening and closing of the contralateral unimpaired hand
  • A glove instrumented with sensors and worn on the unimpaired hand detects the degree of hand opening and determines stimulation intensity
  • Therapy sessions are done with the subject being assisted by the CCFES system.

Intervention Characteristics Common to Both Groups

• 6-week intervention

  1. Home "exercise", daily

    1. Exercise (at home) 2 sessions/day
    2. A "session" consists of 3 (for CCFES) or 4 (for cNMES) 15-min sets separated by 5 min rest
    3. A "set" entails hand opening, closing, and relaxing in response or synchrony to light and sound cues and according to group-specific instructions
  2. Lab "therapy", 2x/week

    1. Two 1.5-hr sessions/week, working on functional hand tasks and tracking task (if possible).
Active Comparator: cNMES

cNMES - Cyclic NeuroMuscular Electrical Stimulation.

  • Preprogrammed cycles of finger and thumb flexor and extensor stimulation repeatedly and automatically close and open the hand without any effort or voluntary intent required by the subject.
  • Subject instructed to relax, not attempt to assist the stimulation, and not to move the contralateral arm/hand during stimulation
  • Therapy sessions are done without the stimulation system

Intervention Characteristics Common to Both Groups

• 6-week intervention

  1. Home "exercise", daily

    1. Exercise (at home) 2 sessions/day
    2. A "session" consists of 3 (for CCFES) or 4 (for cNMES) 15-min sets separated by 5 min rest
    3. A "set" entails hand opening, closing, and relaxing in response or synchrony to light and sound cues and according to group-specific instructions
  2. Lab "therapy", 2x/week

    1. Two 1.5-hr sessions/week, working on functional hand tasks and tracking task (if possible).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum Voluntary Finger Extension Angle (a Measure of Hand Impairment)
Time Frame: 3 months post-treatment.
A custom-built electrogoniometer recorded the angles of the metacarpophalangeal (MP) and proximal interphalangeal (PIP) joints of the index finger simultaneously. Participants were seated with the forearm and wrist supported and stabilized in a neutral posture. From this resting postion, they were instructed to extend their fingers as fully as possible in response to a 4-sec audio cue. The MP and PIP angles were added together, providing a composite measure of degree of finger extension, where 0 degrees corresponds to full extension of the MP and PIP joints. The more negative the angle, the more flexed the finger.
3 months post-treatment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Finger Tracking Error
Time Frame: 3 months post-treatment.
A 30-sec 0.1Hz sine wave track scrolled from right to left on a computer screen in front of the participant. The amplitude of the sine wave was scaled to match the middle 70% of the participant's voluntary finger active range of motion (AROM). A cursor on the computer screen moved up and down as the participant extended and flexed their index finger. The task was to trace the scrolling sine wave with the cursor. Tracking error was the average vertical distance between the cursor and the target trace. Since the track was scaled to the participant's finger AROM, the distance between the cursor and the target trace (and therefore the tracking error) is in units corresponding to the percentage (%) of the participant's finger active range of motion (AROM), hereafter abbreviated %AROM.
3 months post-treatment.
Box and Blocks Score
Time Frame: 3 months post-treatment.
The number of blocks picked up and moved across a barrier in 60 seconds
3 months post-treatment.
Arm Motor Abilities Test
Time Frame: 3 months post-treatment.
The Arm Motor Abilities Test (AMAT) score is an average across 9 different compound activities of daily living (ADL) tasks composed of 1 to 3 component tasks, each of which was scored by a therapist using a 0 to 5 ordinal scale: 0, no attempt to use affected limb; 1, attempt to use affected limb but it doesn't participate functionally; 2, affected limb is used only as a helper or stabilizer; 3, affected limb is used slowly or within synergy patterns; 4, affected limb use almost normal; 5, normal use. Each of the 9 tasks is scored and then the average score across the 9 tasks is calculated, with a range of 0 to 5.
3 months post-treatment.
Fugl-Meyer Assessment (Upper Extremity)
Time Frame: 3 months post-treatment.
The participant was asked to perform specific coordinated and isolated shoulder, elbow, wrist, and hand movements. Each movement was rated by a therapist using a 3-point ordinal scale: 0, cannot perform; 1, perform partially; 2, perform fully) and summed to produce an overall score, with a range of 0 to 66 (the higher the score the better).
3 months post-treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jayme S Knutson, PhD, MetroHealth Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2007

Primary Completion (Actual)

April 1, 2010

Study Completion (Actual)

April 1, 2010

Study Registration Dates

First Submitted

November 27, 2007

First Submitted That Met QC Criteria

November 27, 2007

First Posted (Estimate)

November 29, 2007

Study Record Updates

Last Update Posted (Actual)

December 19, 2018

Last Update Submitted That Met QC Criteria

November 27, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe